Search - tctmd.com

Displaying 81 - 100 of 263

Sort: Relevancy | Date

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

News Daily News

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

L.A. McKeown

April 03, 2018

News Conference News ISET 2018

WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy

Caitlin E. Cox

February 13, 2018

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Caitlin E. Cox

February 07, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Industry News

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

July 11, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

News Daily News

Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting

L.A. McKeown

April 19, 2017

News Conference News ACC 2017

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Todd Neale

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

Advertisement

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Plaque Protrusion an Infrequent but Troubling Complication of Carotid Artery Stenting

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Live From Washington: ACC 2017, Day Three

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content